Concepedia

Lizhi Zeng

LZ

Statistics

Publications

6

Citations

377

H-Index

6

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AstraZeneca (United States)

Lizhi Zeng is an author at The University of Texas MD Anderson Cancer Center specializing in tumor biology, pathology, and cancer research.

Top concepts

Publications per year

1984–2012

6

Publications

6

Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells

Maria Inês Almeida, Milena S. Nicoloso, Lizhi Zeng et al. · Gastroenterology · 2012 · 201 citations · Full text

, , +12

Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway

Kenneth S. Thress, Terry Macintyre, Haiyun Wang et al. · Molecular Cancer Therapeutics · 2009 · 58 citations

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

Alejandro G. Levy, Peter E. Zage, Lauren J. Akers et al. · Investigational New Drugs · 2010 · 40 citations · Full text

, , +9

The selective Trk inhibitor AZ623 inhibits brain‐derived neurotrophic factor–mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan

Peter E. Zage, Timothy C. Graham, Lizhi Zeng et al. · Cancer · 2010 · 31 citations · Full text

A novel therapeutic combination for neuroblastoma

Peter E. Zage, Lizhi Zeng, Shana L. Palla et al. · Cancer · 2010 · 26 citations

1–5 of 6